Purchase Order 75D30123P17037
Award Date 7/3/23
Potential Completion Date 8/19/23
Potential Value $69K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $27,274.50 firm fixed price purchase order to Illumina, Inc. of San Diego, California for lab supplies and MiSeq reagent kits. The contract has no set-aside designation and requires completion by October 14, 2022. The MiSeq reagent kits will support the CDC's genomic sequencing work to advance public health goals such as disease surveillance and outbreak response. Illumina will deliver the...
- The Centers for Disease Control and Prevention (CDC) awarded a $176,623.68 firm fixed price purchase order to Illumina, Inc. for MISEQ REAGENT KITS V3 (600 CYCLE) to be delivered to their Pittsburgh location. The place of performance for this contract is in San Diego, California. The contract period of performance is from September 11, 2023 through November 2, 2023. No subcontractors or set aside designations were identified. The CDC works to protect public health and safety through the...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $148,290.40 contract is for the provision of lab supplies, with a completion date of September 8, 2021. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing instruments, reagents, and services....
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $19,502 purchase order to Illumina, Inc. for ISEQ 100NGS kits. The firm fixed price contract has a period of performance of one day, September 6, 2023. The place of performance will be Illumina's location in Atlanta, Georgia. The CDC is likely procuring the next generation sequencing kits to support genomic surveillance efforts within its broader infectious disease programs. No...
- <p>The CDC Pittsburgh awarded a purchase order to Illumina, Inc. for a MiSeq System valued at $93,529.00 on August 19, 2024, with ultimate completion October 16, 2026. Place of performance is Fort Collins, Colorado. The order is firm fixed price with no set-aside applied, issued under Executive Order 14398.</p>
- The CDC Pittsburgh awarded a $29,595.03 firm fixed-price purchase order to Illumina, Inc. on August 9, 2024, for NextEra XT Library Preparation kits and related reagent supplies required for the agency's validated MiSeq Next-Generation Sequencing (NGS) assay. This assay supports the identification of HIV genetic mutations associated with drug resistance—a critical capability for HIV surveillance and treatment optimization. The contract, which carries no set-aside designation, will be performed...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $23,371 firm fixed-price purchase order to Illumina, Inc. for the ISEQ 100 System on August 24, 2021. The contract, which was completed by September 30, 2023, was issued without a set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing technology. The ISEQ 100 is a compact, entry-level sequencing instrument designed for targeted genomic analysis applications, supporting the CDC's...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Illumina, Inc. a $46,172.80 firm fixed price purchase order for Illumina reagents. The place of performance will be Illumina's facility located in Chamblee, Georgia. The period of performance is from February 7, 2023 through August 15, 2023. CDC Pittsburgh is likely procuring the reagents to support its genomic sequencing and bioinformatics programs that help public health agencies detect,...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Illumina, Inc., a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. The $19,542.00 award is for 2023 MiSeq Silver support and system health check services. The contract has a completion date of September 24, 2024 and was awarded on September 28, 2023. There was no set-aside designation used for this procurement....
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $20,400.00, is for the provision of ILLUMINA - AMPLISEQ products and services, with a period of performance through September 30, 2024. The contract has no set-aside designation. Illumina has a history of providing sequencing equipment and consumables to support...